This review assessed the effect of consuming a low protein diet, compared to a normal protein intake, on renal outcomes in people with diabetes. The authors concluded that no strong improvements in kidney function were demonstrated. Despite poor reporting of some aspects of the review process, this conclusion is likely to be reliable.
Study selection
Randomised controlled trials (RCTs) of low protein diets in participants with any type of diabetes were included (no definition of the comparator 'normal' protein diet was provided). Trials using a crossover design were excluded due to the possibility of carry-over effects. Included trials had to have a minimum follow-up period of six months and report at least one of the following outcomes: change in glomerular filtration rate or creatinine clearance rate, albuminuria or proteinuria. Change in glomerular filtration rate or creatinine clearance rate was the primary outcome.
Five different methods of assessing protein excretion were used amongst the included trials: albumin excretion rate (mg/24 hours), micro-albuminuria (g/day), urine albumin excretion (mg/24 hours), 24 hour proteinuria (g/24 hours) and albuminuria (mg/24 hours). Included trials studied participants with type 1 diabetes only, type 2 diabetes only or included participants with either type of diabetes. The mean age of included participants ranged from 30 to 64, the percentage of males ranged from 36 to 90%, and baseline glomerular filtration rate ranged from 43.9 to 131 mL per minute per 1.73m 2 . Prescribed protein intake in the low protein diet groups was either 0.6 or 0.8 g/kg/day; actual intake ranged from 0.71 to 1.10 g/kg/day. Protein intake in the normal diet group ranged from 1.02 to 2.0 g/kg/day. The authors did not state how the papers were selected for the review, or how many reviewers performed the selection.
Assessment of study quality
The Jadad scale was used for the quality assessment of RCTs, but the content of the scale was not reported. Up to 5 points could be awarded for the presence of adequate randomisation and allocation concealment, blinding and description of withdrawals and drop-outs.
The authors did not state how many reviewers performed the validity assessment.
Data extraction
Changes from baseline in glomerular filtration rate or creatinine clearance rate (used interchangeably to estimate change in glomerular filtration rate), urinary protein excretion and serum albumin concentration were extracted. Results from analysis of timed urine specimens for proteinuria and albuminuria were converted to grams per 24 hours. Data on glycated haemoglobin (HbA 1c ) and serum albumin were also extracted.
Data were extracted by two reviewers and any disagreements were resolved by discussion between them and by consultation with the third author. A fixed-effect model was used to combine data; in the presence of statistical heterogeneity (P<0.10), a random-effects model was employed. Weighted mean differences (WMD) were combined for changes from baseline in glomerular filtration rate, HbA 1c and serum albumin concentrations. For outcomes assessed using different measurement scales, i.e. changes in urinary protein excretion, the standardised mean difference (SMD) was estimated. Standard deviations (SDs) were imputed using interquartile ranges and full ranges.
Methods of synthesis
Statistical heterogeneity was assessed using the I 2 statistic. Meta-regression used to examine any effect from potential sources of heterogeneity: changes in glomerular filtration rate, proteinuria, HBA 1c , and serum albumin concentrations. A priori sensitivity analyses of the relative effects of low protein diets on glomerular filtration rate according to type of diabetes were conducted. Publication bias was assessed by using weighted regression and presentation of data in a funnel plot.
Results of the review
Eight RCTs with 519 participants were eligible for inclusion. Three trials had a Jadad score of 4 out of 5 points, three scored 3 and two scored 2 out of 5 points. No further details of the quality assessment were provided. No evidence of publication bias was identified visually on the funnel plot or statistically (p=0.43). Average protein intake in the low protein diet group was 1.27g/kg/day compared to 0.91g/kg/day in the normal protein diet group, but nevertheless was around 20% greater than the recommended dietary allowance.
Low protein diets were found to have no statistically significant effect on changes in glomerular filtration rate either overall (WMD: 0.50mL.min -1 /1.73m -2 , 95% CI -1.43 to 2.42; eight RCTs) or for those with type 1 or type 2 diabetes, and no significant heterogeneity was identified (overall I 2 =0%, p=0.53).
A significant decrease in proteinuria was identified in the low protein diet group compared to the normal protein diet group (SMD -0.69 units, 95% CI -1.14 to -0.23; eight RCTs), but the trial results were significantly heterogeneous (I 2 =81.4%), so the reported result was taken from a random-effects model.
A significant reduction in glycated haemoglobin of 31% was reported for the low protein diet group compared to the normal protein group (WMD -0.31%, 95% CI -0.53 to -0.09; I 2 =34.0%, seven RCTs). The reduction in serum albumin in the low protein diet group was also significantly greater than for the normal protein diet group (WMD -1.18g/L, 95% CI -1.33 to -1.03; I 2 =43.0%, four RCTs). No statistically significant heterogeneity was identified for the analyses (as reported in I 2 results).
